Robust Market Growth Predicted for MEA Cardiac Valve Repair Devices

Increased investments in healthcare infrastructure and advancements in medical research facilities are fostering the growth of cardiac valve repair devices in the Middle East and Africa (MEA). In addition, the region’s aging population, improved life expectancy, and greater awareness among both patients and physicians about available treatment options contribute to the rising demand for those devices.

As a result, the MEA cardiac valve repair devices market is expected to experience significant growth in the coming years, according to GlobalData. The company’s latest models show mitral valve annuloplasty devices will experience the region’s strongest growth, expanding 8% annually through 2034. 

“Valve repair is generally preferred over replacement for eligible patients due to its association with lower short-term and long-term mortality and morbidity rates,” GlobalData Medical Analyst Thomas Fleming said. “The growing prevalence of mitral valve regurgitation and valvular stenosis further supports the demand for repair devices. Additionally, the cost of valve repair devices and procedures is lower compared to alternative treatments, making them a viable option for healthcare providers and patients. However, challenges exist with the popularity of transcatheter mitral valve repair (TMVR) and transcatheter aortic valve replacement (TAVR) devices. The increased adoption and availability of these devices could lead to disruptions.”

Currently, Medtronic holds the highest market share in the MEA region for cardiac valve repair devices, followed by Edwards Lifesciences. As the market evolves, continued investments in research and innovation will be crucial in shaping the competitive landscape in the MEA.

“South Africa mirrors the broader regional trends, standing among the highest healthcare investors in Africa. As the country’s aging population continues to grow, it is expected to see an increasing adoption of valve repair treatments,” Fleming stated.